Overview

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
0
Participant gender:
All
Summary
Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia and marrow hypoplasia.The theoretical basis for marrow failure includes primary defects in or damage to the stem cell or the marrow microenvironment
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Criteria
Inclusion Criteria:

- All patients with severe and very severe aplastic anemia for stem cell therapy.

Exclusion Criteria:

1- Contraindication to stem cell transplantation. 2 - Patients associated co-morbidities.